Fructose overfeeding in first-degree relatives of type 2 diabetic patients impacts energy metabolism and mitochondrial functions in skeletal muscle

Molecular Nutrition and Food Research

Volumn 60, Issue 12, 2016, Pages 2691-2699

  Seyssel, Kevin ^a,b,c   Meugnier, Emmanuelle ^a,b   Lê, Kim Anne ^d   Durand, Christine ^a,b   Disse, Emmanuel ^a,b,c   Blond, Emilie ^a,b,c   Pays, Laurent ^a,b,e   Nataf, Serge ^a,b,e   Brozek, John ^f   Vidal, Hubert ^a,b,c   Tappy, Luc ^d   Laville, Martine ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b CarMeN   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f Parc Eurasante Lille Metropole   (France)

Author keywords

Energy metabolism; Gene regulation; High fructose diet; Lipid oxidation; Skeletal muscle

Indexed keywords

FRUCTOSE; NR4A2 PROTEIN, HUMAN; NUCLEAR RECEPTOR RELATED FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTOME;

ADULT; BLOOD; CELL LINE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE CELL; YOUNG ADULT;

ADULT; CELL LINE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIET; ENERGY METABOLISM; FRUCTOSE; GENE EXPRESSION PROFILING; HUMANS; LIPID METABOLISM; MALE; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PPAR ALPHA; TRANSCRIPTOME; YOUNG ADULT;

EID: 84987815254     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600407     Document Type: Article

References (42)

1. Bray, G. A., Nielsen, S. J., Popkin, B. M., Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 2004, 79, 537–543.
2. Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T. et al., Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899–906.
3. Tappy, L., Lê, K.-A., Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23–46.
4. Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. et al., Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392–2404.
5. Assy, N., Nasser, G., Kamayse, I., Nseir, W. et al., Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can. J. Gastroenterol. 2008, 22, 811–816.
6. Schulze, M. B., Manson, J. E., Ludwig, D. S., Colditz, G. A. et al., Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292, 927–934.
7. Welsh, J. A., Sharma, A., Abramson, J. L., Vaccarino, V. et al., Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010, 303, 1490–1497.
8. Bizeau, M. E., Pagliassotti, M. J., Hepatic adaptations to sucrose and fructose. Metab. Clin. Exp. 2005, 54, 1189–1201.
9. Wei, Y., Pagliassotti, M. J., Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E926–E933.
10. Wei, Y., Wang, D., Pagliassotti, M. J., Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes. J. Nutr. 2005, 135, 1642–1646.
11. Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C. et al., Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009, 119, 1322–1334.
12. Egli, L., Lecoultre, V., Theytaz, F., Campos, V. et al., Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects. Diabetes 2013, 62, 2259–2265.
13. Faeh, D., Minehira, K., Schwarz, J.-M., Periasamy, R. et al., Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005, 54, 1907–1913.
14. Lê, K.-A., Ith, M., Kreis, R., Faeh, D. et al., Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760–1765.
15. Nagai, Y., Nishio, Y., Nakamura, T., Maegawa, H. et al., Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E1180–E1190.
16. Matsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M. et al., Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 2004, 53, 560–569.
17. Bezerra, R. M., Ueno, M., Silva, M. S., Tavares, D. Q. et al., A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J. Nutr. 2000, 130, 1531–1535.
18. Li, P., Koike, T., Qin, B., Kubota, M. et al., A high-fructose diet impairs Akt and PKCzeta phosphorylation and GLUT4 translocation in rat skeletal muscle. Horm. Metab. Res. 2008, 40, 528–532.
19. Crescenzo, R., Bianco, F., Coppola, P., Mazzoli, A. et al., Increased skeletal muscle mitochondrial efficiency in rats with fructose-induced alteration in glucose tolerance. Br. J. Nutr. 2013, 110, 1996–2003.
20. Hokayem, M., Blond, E., Vidal, H., Lambert, K. et al., Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care 2013, 36, 1454–1461.
21. Couchepin, C., Lê, K.-A., Bortolotti, M., da Encarnaçao, J. A. et al., Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects. Diabetes Care 2008, 31, 1254–1256.
22. Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S. et al., Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann. Intern. Med. 1990, 113, 909–915.
23. Alligier, M., Meugnier, E., Debard, C., Lambert-Porcheron, S. et al., Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J. Clin. Endocrinol. Metab. 2012, 97, E183–E192.
24. Seyssel, K., Alligier, M., Meugnier, E., Chanseaume, E. et al., Regulation of energy metabolism and mitochondrial function in skeletal muscle during lipid overfeeding in healthy men. J. Clin. Endocrinol. Metab. 2014, 99, E1254–E1262.
25. Gautier, L., Cope, L., Bolstad, B. M., Irizarry, R. A., affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20, 307–315.
26. Smyth, G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3, doi: 10.2202/1544-6115.1027.
27. Huang, D. W., Sherman, B. T., Lempicki, R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37, 1–13.
28. Montojo, J., Zuberi, K., Rodriguez, H., Kazi, F. et al., GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 2010, 26, 2927–2928.
29. Perrin, L., Loizides-Mangold, U., Skarupelova, S., Pulimeno, P. et al., Human skeletal myotubes display a cell-autonomous circadian clock implicated in basal myokine secretion. Mol. Metab. 2015, 4, 834–845.
30. Cozzone, D., Debard, C., Dif, N., Ricard, N. et al., Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 2006, 49, 990–999.
31. Teff, K. L., Grudziak, J., Townsend, R. R., Dunn, T. N. et al., Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J. Clin. Endocrinol. Metab. 2009, 94, 1562–1569.
32. Heden, T. D., Liu, Y., Park, Y.-M., Nyhoff, L. M. et al., Moderate amounts of fructose- or glucose-sweetened beverages do not differentially alter metabolic health in male and female adolescents. Am. J. Clin. Nutr. 2014, 100, 796–805.
33. Lê, K.-A., Faeh, D., Stettler, R., Ith, M. et al., A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006, 84, 1374–1379.
34. Rome, S., Lecomte, V., Meugnier, E., Rieusset, J. et al., Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol. Genomics 2008, 34, 327–337.
35. Stephens, F. B., Constantin-Teodosiu, D., Greenhaff, P. L., New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J. Physiol. 2007, 581, 431–444.
36. McGarry, J. D., The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homoeostasis and new insights into its molecular features. Biochem. Soc. Trans. 1995, 23, 321–324.
37. Samocha-Bonet, D., Campbell, L. V., Mori, T. A., Croft, K. D. et al., Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans. PLoS ONE 2012, 7, e36320.
38. Lefebvre, P., Chinetti, G., Fruchart, J.-C., Staels, B., Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006, 116, 571–580.
39. Pearen, M. A., Muscat, G. E. O., Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 2010, 24, 1891–1903.
40. Oita, R. C., Mazzatti, D. J., Lim, F. L., Powell, J. R. et al., Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats. Mech. Ageing Dev. 2009, 130, 240–247.
41. Tappy, L., Randin, J. P., Felber, J. P., Chiolero, R. et al., Comparison of thermogenic effect of fructose and glucose in normal humans. Am. J. Physiol. 1986, 250, E718–E724.
42. Shinozaki, K., Kashiwagi, A., Masada, M., Okamura, T., Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state. J. Pharmacol. Sci. 2003, 91, 187–191.